Skip to content

Clinical trials

Terminated Phase 3 Nervous System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nervous System Diseases Phase: Phase 3 Status: Terminated Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20141
20163
20171
20181
20213
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Xenon Pharmaceuticals Inc.2
Alzheon Inc.1
Auris Medical, Inc.1
Hoffmann-La Roche1
Hospira, now a wholly owned subsidiary of Pfizer1
Kyntra Bio1
PTC Therapeutics1
Pfizer1
Tonix Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nervous System Diseases12
Central Nervous System Diseases7
Alzheimer Disease5
Brain Diseases5
Dementia5
Mental Disorders5
Neurodegenerative Diseases4
Tauopathies4
Delirium3
Disease3

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.